Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Mast Cell Leukemia. Data from NIH RePORTER, last 36 months.
Mast Cell Leukemia has emerging NIH research funding with 1 grant totaling $1.7M.
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Mast Cell Leukemia. Strongest funded area: Basic Science.
6 clinical trials registered but no NIH-funded clinical or translational research grants found for mast cell leukemia. Trials may be industry-sponsored or funded through non-NIH sources.
These grants mention Mast Cell Leukemia as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.